Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury
Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam
Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam
View: Text | PDF
Research Article Cell biology Muscle biology

Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury

  • Text
  • PDF
Abstract

Spinal cord injury (SCI) evokes profound dysfunction in hollow organs such as the urinary bladder and gut. Current treatments are limited by a lack of molecular data to inform novel therapeutic avenues. Previously, we showed that systemic treatment with the neuroprotective agent inosine improved bladder function following SCI in rats. Here, we applied integrated multi-omics analysis to explore molecular alterations in the bladder over time and their sensitivity to inosine following SCI. Canonical signaling pathways regulated by SCI included those associated with protein synthesis, neuroplasticity, wound healing, and neurotransmitter degradation. Upstream regulator and causal network analysis predicted multiple effectors of DNA damage response signaling following injury, including poly-ADP ribose phosphorylase-1 (PARP1). Markers of DNA damage (γH2AX, ATM/ATR substrates) and PARP activity were increased in bladder tissue following SCI and attenuated with inosine treatment. Inosine treatment also attenuated oxidative DNA damage in rat bladder cells in vitro. Proteomics analysis suggested that SCI induced changes in protein synthesis–, neuroplasticity-, and oxidative stress–associated pathways, a subset of which were shown in transcriptomics data to be inosine sensitive. These findings provide insights into the molecular landscape of the bladder following SCI and identify key inosine-sensitive pathways associated with injury.

Authors

Ali Hashemi Gheinani, Bryan S. Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano, Mary Piper, Justin F. Cotellessa, Dijana Vitko, Haiying Li, Manubhai Kadayil Prabhakaran, Vivian Cristofaro, John Froehlich, Richard S. Lee, Wei Yang, Maryrose P. Sullivan, Jill A. Macoska, Rosalyn M. Adam

×

Figure 7

Immunostaining for causal network and pathway validation.

Options: View larger image (or click on image) Download as PowerPoint
Immunostaining for causal network and pathway validation.
(A, D, and G) ...
(A, D, and G) Bladder sections from SCI and Control rats were stained for phosphorylated histone H2AX (γH2AX) (green) and SM22a (red) (A), poly/mono ADP Ribosylation (PAR) (red) and pan cytokeratin (Pan-Ck) (green) (D), or pATM-substrates (pATM-sub) (red) and pan-cytokeratin (Pan-Ck) (green) (G). Nuclei were visualized with DAPI (magnification, 20×). White dashed rectangles indicate regions of tissue visualized at 100×. Images were analyzed with ImageJ-based macro outlined in Supplemental Figure 13 that quantified nuclear staining for the markers of interest. (B, E, and H) Quantification of percentage of positive nuclei for each DNA damage–associated marker. (C, F, and I) Quantification of the nuclear signal intensity for each DNA damage–associated marker. A total of 5–15 fields of view were captured at 20× with > 5,000 nuclei represented for each of 3 biological replicates per condition. Significance was determined by 1-way ANOVA followed by Tukey’s multiple comparisons test. Adjusted P values were used to report the significance of the differences. *P < 0.05, **P < 0.01, versus control. #P < 0.05, ##P < 0.01, versus SCI.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts